Glycomic analysis of high density lipoprotein shows a highly sialylated particle. [PDF]
Many of the functional proteins and lipids in high density lipoprotein (HDL) particles are potentially glycosylated, yet very little is known about the glycoconjugates of HDL.
German, J Bruce +6 more
core +1 more source
Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion1[S]
Humans and mice lacking angiopoietin-like protein 3 (ANGPTL3) have pan-hypolipidemia. ANGPTL3 inhibits two intravascular lipases, LPL and endothelial lipase, and the low plasma TG and HDL-cholesterol levels in ANGPTL3 deficiency reflect increased ...
Yan Wang +5 more
semanticscholar +1 more source
Plasma very low density lipoproteins contain a single molecule of apolipoprotein B
Rat and human very low density lipoproteins (VLDL) were fractionated by zonal ultracentrifugation, yielding sharply defined fractions with narrow sedimentation limits.
J Elovson +7 more
doaj +1 more source
Increased levels of apolipoprotein B (apoB)-containing lipoproteins, such as low density lipoproteins (LDL) and chylomicron remnants, are associated with the development of atherosclerosis.
Shin-ya Morita
semanticscholar +1 more source
VLDL-bound lipoprotein lipase facilitates the cholesteryl ester transfer protein-mediated transfer of cholesteryl esters from HDL to VLDL [PDF]
In recent years, it has been established that lipoprotein lipase (LPL) is partly associated with circulating lipoproteins. This report describes the effects of physiological amounts of very low density lipoprotein (VLDL)-bound LPL on the cholesteryl ester transfer protein (CETP)-mediated cholesteryl ester transfer (CET) from high density lipoprotein ...
Valérie Pruneta +6 more
openaire +3 more sources
Alpha-tocopherol is secreted from rat liver in very low density lipoproteins
Three separate studies were carried out to test the hypothesis that rat liver secretes vitamin E (alpha-tocopherol) within very low density lipoproteins (VLDL).
W Cohn, F Loechleiter, F Weber
doaj +1 more source
Background It is uncertain whether pharmacological reductions in very‐low‐density lipoproteins (VLDLs), and their component triglyceride and cholesterol could reduce residual risk of atherosclerotic cardiovascular disease (ASCVD) events among individuals
P. Lawler +6 more
semanticscholar +1 more source
Apolipoprotein E and Atherosclerosis: From Lipoprotein Metabolism to MicroRNA Control of Inflammation. [PDF]
Apolipoprotein (apo) E stands out among plasma apolipoproteins through its unprecedented ability to protect against atherosclerosis. Although best recognized for its ability to mediate plasma lipoprotein clearance in the liver and protect against ...
Hasty +6 more
core +2 more sources
Secretion of apolipoproteins in very low density and high density lipoproteins by perfused rat liver
The incorporation of labeled amino acids into the peptides of very low density lipoproteins (VLDL) and high density lipoproteins (HDL) secreted by perfused rat liver was studied using a Ringer—albumin solution in the perfusate in place of serum to ...
Simon-Pierre Noel, David Rubinstein
doaj +1 more source
Paraoxonase gene polymorphisms and haplotype analysis in a stroke population [PDF]
Peer reviewedPublisher ...
Cheung, J +6 more
core +2 more sources

